Compounds And Compositions For Intracellular Delivery Of Agents

Patent No. EP3394030 (titled "Compounds And Compositions For Intracellular Delivery Of Agents") was filed by Moderna on Dec 22, 2016. The application was issued on Feb 12, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTSep 22, 2022BOULT WADE TENNANT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3394030

MODERNA
Application Number
EP16831870A
Filing Date
Dec 22, 2016
Status
Patent Maintained As Amended
Jan 10, 2025
Publication Date
Feb 12, 2025